You are here

Business Wire

All our partners

BUSINESS WIRE helps companies to disseminate their full text press releases, regulatory information and multimedia documents effectively and securely to news agencies, journalists, analysts and investors the world over.

https://www.businesswire.com
12/09/2019 - 22:58

Darzalex®▼ (daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Ineligible for Transplant

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today overall survival (OS) results from the Phase 3 ALCYONE study, which showed the addition of Darzalex® (daratumumab) to bortezomib, melphalan and prednisone (D-VMP) improved OS in patients with newly diagnosed, transplant-ineligible multiple myeloma, with a 40 percent reduction in the risk of death compared to VMP alon...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today overall survival (OS) results from the Phase 3 ALCYONE study, which showed the addition of Darzalex® (daratumumab) to bortezomib, melphalan and prednisone (D-VMP) improved OS in patients with newly diagnosed, transplant-ineligible multiple myeloma, with a 40 percent reduction in the risk of death compared to VMP alon...


12/09/2019 - 22:48

MoEngage Inc. Achieves Amazon Web Services Retail Experience Competency Status

MoEngage Inc, an intelligent customer engagement platform, announced today that it achieved Amazon Web Services (AWS) Retail Competency. AWS Retail Competency Partners have demonstrated technical proficiency and proven customer success across numerous innovative solution areas in retail spanning Data Lakes, AI/ML, Voice, Recognition, IoT, Microservices, and Retail Transformation. AWS Retai...

MoEngage Inc, an intelligent customer engagement platform, announced today that it achieved Amazon Web Services (AWS) Retail Competency. AWS Retail Competency Partners have demonstrated technical proficiency and proven customer success across numerous innovative solution areas in retail spanning Data Lakes, AI/ML, Voice, Recognition, IoT, Microservices, and Retail Transformation. AWS Retai...


12/09/2019 - 22:15

PanTheryx Bovine Colostrum Recognized as GRAS

PanTheryx, a biotechnology company committed to realizing the potential of bovine colostrum-based therapies to address a wide range of health conditions, today announced that an independent expert panel of scientists affirmed its bovine colostrum as GRAS (Generally Recognized As Safe) for specific food and beverage uses. The GRAS recognition relates to PanTheryx’s proprietary colostrum and ope...

PanTheryx, a biotechnology company committed to realizing the potential of bovine colostrum-based therapies to address a wide range of health conditions, today announced that an independent expert panel of scientists affirmed its bovine colostrum as GRAS (Generally Recognized As Safe) for specific food and beverage uses. The GRAS recognition relates to PanTheryx’s proprietary colostrum and ope...


12/09/2019 - 20:45

Kite Presents Positive Results From Pivotal ZUMA-2 Trial in Relapsed or Refractory Mantle Cell Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), today announced primary results from ZUMA-2, a global, multicenter, single-arm, open-label Phase 2 study of KTE-X19, an investigational CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients with relapsed or refractory mantle cell lymphoma (MCL). After a single infusion of KTE-X19, the best objective response via independent radiologic cen...

Kite, a Gilead Company (Nasdaq: GILD), today announced primary results from ZUMA-2, a global, multicenter, single-arm, open-label Phase 2 study of KTE-X19, an investigational CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients with relapsed or refractory mantle cell lymphoma (MCL). After a single infusion of KTE-X19, the best objective response via independent radiologic cen...


12/09/2019 - 20:45

Kite and the CIBMTR® Present Positive Findings From Real-World Use of Yescarta® (Axicabtagene Ciloleucel) in Relapsed or Refractory Large B-Cell Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), and the CIBMTR® (Center for International Blood and Marrow Transplant Research®), the research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW), today announced findings from an ongoing post-marketing study evaluating the safety and efficacy of Yescarta® (axicabtagene ciloleucel) in a...

Kite, a Gilead Company (Nasdaq: GILD), and the CIBMTR® (Center for International Blood and Marrow Transplant Research®), the research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW), today announced findings from an ongoing post-marketing study evaluating the safety and efficacy of Yescarta® (axicabtagene ciloleucel) in a...


12/09/2019 - 18:57

Post Malone and Crocs Launch Fourth Collaboration

Crocs, Inc. (NASDAQ: CROX), a global leader in innovative, casual footwear for women, men and children, today announced their latest product collaboration with multi-platinum recording artist Post Malone. This ground-breaking fourth installment of the Post Malone x Crocs collaboration series features the Post Malone x Crocs Duet Max Clog, an innovative clog silhouette with a unique blue and bl...

Crocs, Inc. (NASDAQ: CROX), a global leader in innovative, casual footwear for women, men and children, today announced their latest product collaboration with multi-platinum recording artist Post Malone. This ground-breaking fourth installment of the Post Malone x Crocs collaboration series features the Post Malone x Crocs Duet Max Clog, an innovative clog silhouette with a unique blue and bl...


12/09/2019 - 18:00

Knopp Biosciences Presents Data Further Characterizing Its Lead Kv7.2 Activator Drug Candidate for the Treatment of KCNQ2 Epileptic Encephalopathy at the American Epilepsy Society’s 2019 Annual Meeting

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for immunological and neurological diseases with high unmet need, today presented data characterizing KB-3061, the lead molecule in the Company’s Kv7 ion channel platform, at the American Epilepsy Society’s (AES) 2019 Annual Meeting in Baltimore, Maryland. Knopp is adv...

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for immunological and neurological diseases with high unmet need, today presented data characterizing KB-3061, the lead molecule in the Company’s Kv7 ion channel platform, at the American Epilepsy Society’s (AES) 2019 Annual Meeting in Baltimore, Maryland. Knopp is adv...


12/09/2019 - 16:46

Murray Energy Corporation Posts Information to its Website Related to Murray Metallurgical

Beginning on December 2, 2019, Murray Energy Corporation (the “Company”) engaged in confidential discussions under separate confidentiality agreements with certain members of an ad hoc group of superpriority lenders related Murray Metallurgical Coal Holdings, LLC and its subsidiaries (collectively, “Murray Metallurgical”). The confidentiality agreements require the Company to publicly disclo...

Beginning on December 2, 2019, Murray Energy Corporation (the “Company”) engaged in confidential discussions under separate confidentiality agreements with certain members of an ad hoc group of superpriority lenders related Murray Metallurgical Coal Holdings, LLC and its subsidiaries (collectively, “Murray Metallurgical”). The confidentiality agreements require the Company to publicly disclo...


12/09/2019 - 16:00

Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and Investigational Gene Therapy at ASH 2019

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that underscore its commitment to advancing treatments for rare bleeding disorders by incorporating real-world data and developing innovative adeno-associated virus (AAV) gene therapies. Understanding Real-...

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that underscore its commitment to advancing treatments for rare bleeding disorders by incorporating real-world data and developing innovative adeno-associated virus (AAV) gene therapies. Understanding Real-...


12/09/2019 - 16:00

Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting

Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of results from the ECHELON-1 and ECHELON-2 frontline phase 3 trials of ADCETRIS® (brentuximab vedotin). These analyses were presented at the 61st Annual Meeting of the American Society of Hematology (ASH) taking place December 7-10, 2019 in Orlando, Fla. ADCET...

Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of results from the ECHELON-1 and ECHELON-2 frontline phase 3 trials of ADCETRIS® (brentuximab vedotin). These analyses were presented at the 61st Annual Meeting of the American Society of Hematology (ASH) taking place December 7-10, 2019 in Orlando, Fla. ADCET...

12/10/2019 - 22:00

 Lattice Accelerates FPGA Design with New Lattice Radiant 2.0 Design Software

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the availability of the latest version of its popular software design tool for FPGAs, Lattice Radiant™ 2.0. In addition to adding support for higher density devices like the new CrossLink-NX™ FPGA family, the updated design tool also offers new features that make it faster and easier than ever ...

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the availability of the latest version of its popular software design tool for FPGAs, Lattice Radiant™ 2.0. In addition to adding support for higher density devices like the new CrossLink-NX™ FPGA family, the updated design tool also offers new features that make it faster and easier than ever ...


12/10/2019 - 22:00

New Lattice CrossLink-NX FPGAs Bring Power and Performance Leadership to Embedded Vision and Edge AI Applications

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the first FPGA developed on its new Lattice Nexus™ FPGA platform, CrossLink-NX™. This new FPGA provides the low power, small form factor, reliability, and performance that developers need to create innovative embedded vision and AI solutions for communications, compute, industrial, automotive, ...

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the first FPGA developed on its new Lattice Nexus™ FPGA platform, CrossLink-NX™. This new FPGA provides the low power, small form factor, reliability, and performance that developers need to create innovative embedded vision and AI solutions for communications, compute, industrial, automotive, ...


12/10/2019 - 22:00

Lattice Announces New Low Power FPGA Platform

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced its new low power FPGA platform, Lattice Nexus™. The platform is architected to deliver power-efficient performance that will benefit developers of a wide range of applications, including AI for IoT, video, hardware security, embedded vision, 5G infrastructure and industrial/automotive automati...

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced its new low power FPGA platform, Lattice Nexus™. The platform is architected to deliver power-efficient performance that will benefit developers of a wide range of applications, including AI for IoT, video, hardware security, embedded vision, 5G infrastructure and industrial/automotive automati...


12/10/2019 - 21:00

Hydrogène de France Announces the World's First Plant for Mass Production of High-Powered Fuel Cells (Over 1 MW)

Hydrogène de France (HDF) becomes a French industrial company by launching its high-powered fuel cell production plant in Bordeaux. This plant, with an annual production capacity of 50 MW, will be the first in the world to mass produce high-powered PACs (greater than 1 MW) using PEM (Proton Exchange Membrane) technology. The industrialization and standardization of these systems reduces their ...

Hydrogène de France (HDF) becomes a French industrial company by launching its high-powered fuel cell production plant in Bordeaux. This plant, with an annual production capacity of 50 MW, will be the first in the world to mass produce high-powered PACs (greater than 1 MW) using PEM (Proton Exchange Membrane) technology. The industrialization and standardization of these systems reduces their ...


12/10/2019 - 19:12

Nel ASA: Receives Purchase Order for a 3.5 MW Electrolyser from ENGIE

Nel Hydrogen Electrolyser AS, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order, following a previously announced contract, for a 3.5 MW electrolyser from ENGIE. The electrolyser is an element of ENGIE's hydrogen solution to produce renewable hydrogen for the world's largest fuel cell electric mining haul truck for Anglo American, a global mining company, and is scheduled t...

Nel Hydrogen Electrolyser AS, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order, following a previously announced contract, for a 3.5 MW electrolyser from ENGIE. The electrolyser is an element of ENGIE's hydrogen solution to produce renewable hydrogen for the world's largest fuel cell electric mining haul truck for Anglo American, a global mining company, and is scheduled t...


12/10/2019 - 17:40

Monument Re Acquires Cattolica Life from Cattolica Assicurazioni

Monument Re announced today that, subject to regulatory approval, it has acquired Cattolica Life DAC from Cattolica Assicurazioni. Cattolica Life is a life insurer domiciled in Ireland which ceased new activity since 2017. The transaction will have no impact on Cattolica Life DAC clients and policyholders. Change of control of the company will follow satisfaction of customary closing conditi...

Monument Re announced today that, subject to regulatory approval, it has acquired Cattolica Life DAC from Cattolica Assicurazioni. Cattolica Life is a life insurer domiciled in Ireland which ceased new activity since 2017. The transaction will have no impact on Cattolica Life DAC clients and policyholders. Change of control of the company will follow satisfaction of customary closing conditi...


12/10/2019 - 17:00

SugarCRM Reimagines the Future of Customer Experience

SugarCRM Inc.®, the company that helps organizations deliver exceptional customer experiences, is driving the future of the industry as the only vendor providing customers a complete view of their data, both historical and forward-looking with its time-aware customer experience (CX) platform. The time-aware foundation is one-of-a-kind, recording, storing and making available all the data neede...

SugarCRM Inc.®, the company that helps organizations deliver exceptional customer experiences, is driving the future of the industry as the only vendor providing customers a complete view of their data, both historical and forward-looking with its time-aware customer experience (CX) platform. The time-aware foundation is one-of-a-kind, recording, storing and making available all the data neede...


12/10/2019 - 15:46

Panda Biotech Plans the Largest Industrial Hemp Processing Facility for Fiber and Cellulose in the United States

Dallas-based Panda Biotech today announced it is developing its first industrial hemp processing facility to produce high-quality, textile-grade fiber and premium cellulose. The “Panda High Plains Hemp Gin,” to be located in Lubbock County, Texas, is expected to be the largest hemp decortication center in the United States and one of the largest in the world. Panda Biotech plans on deploying...

Dallas-based Panda Biotech today announced it is developing its first industrial hemp processing facility to produce high-quality, textile-grade fiber and premium cellulose. The “Panda High Plains Hemp Gin,” to be located in Lubbock County, Texas, is expected to be the largest hemp decortication center in the United States and one of the largest in the world. Panda Biotech plans on deploying...


12/10/2019 - 15:13

Darzalex®▼ (daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing that the addition of Darzalex® (daratumumab) to carfilzomib (Kyprolis®▼) and dexamethasone (DKd), compared to carfilzomib and dexamethasone (Kd) alone, significantly improved progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma, resulting ...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing that the addition of Darzalex® (daratumumab) to carfilzomib (Kyprolis®▼) and dexamethasone (DKd), compared to carfilzomib and dexamethasone (Kd) alone, significantly improved progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma, resulting ...


12/10/2019 - 15:07

Genesis Co-Founder Michael Watkins Is Named One of the World’s Most Influential Business Thinkers

Michael Watkins, leadership transitions expert and best-selling author of the classic onboarding reference The First 90 Days, was named one of the world’s most influential business thinkers by Thinkers50. Among those also included in the prestigious rankings were W. Chan Kim, Renée Mauborgne, Roger Martin, Amy Edmondson, and Daniel Pink. This press release features multimedia. View the full re...

Michael Watkins, leadership transitions expert and best-selling author of the classic onboarding reference The First 90 Days, was named one of the world’s most influential business thinkers by Thinkers50. Among those also included in the prestigious rankings were W. Chan Kim, Renée Mauborgne, Roger Martin, Amy Edmondson, and Daniel Pink. This press release features multimedia. View the full re...

12/11/2019 - 22:15

IFF Declares Dividend for Fourth Quarter 2019

Regulatory News: IFF (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF), a leading innovator of taste, scent and nutrition announced that its Board of Directors has declared a regular quarterly cash dividend of $0.75 per share of its common stock, payable on January 7, 2020 to shareholders of record as of December 27, 2019. Welcome to IFF At IFF (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF), we’re us...

Regulatory News: IFF (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF), a leading innovator of taste, scent and nutrition announced that its Board of Directors has declared a regular quarterly cash dividend of $0.75 per share of its common stock, payable on January 7, 2020 to shareholders of record as of December 27, 2019. Welcome to IFF At IFF (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF), we’re us...


12/11/2019 - 22:05

Kite Submits Biologics License Application to U.S. Food and Drug Administration for Company’s Second CAR T Cell Therapy

Kite, a Gilead Company (Nasdaq: GILD), today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the investigational chimeric antigen receptor (CAR) T cell therapy, KTE-X19, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). The BLA submission is based on data from the Phase 2 ZUMA-2...

Kite, a Gilead Company (Nasdaq: GILD), today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the investigational chimeric antigen receptor (CAR) T cell therapy, KTE-X19, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). The BLA submission is based on data from the Phase 2 ZUMA-2...


12/11/2019 - 18:00

PTW International Announces Orange Rock Studios, Their Product and Game Development Arm

Pole to Win International, Ltd. (PTW), the industry-leading video games and tech services outsourcer, today announced the launch of its product and game development arm, Orange Rock Studios. Orange Rock Studios will enhance the service offering of PTW, a gaming industry stalwart with an established and diverse dossier of top-tier clients across multiple verticals. “The time to be disruptive ...

Pole to Win International, Ltd. (PTW), the industry-leading video games and tech services outsourcer, today announced the launch of its product and game development arm, Orange Rock Studios. Orange Rock Studios will enhance the service offering of PTW, a gaming industry stalwart with an established and diverse dossier of top-tier clients across multiple verticals. “The time to be disruptive ...


12/11/2019 - 17:30

Fastly Shares the Most Notable Internet Infrastructure Milestones of 2019, and What 2020 Might Bring for the Expansion of Platform-Independent Computing

Fastly, Inc. (NYSE: FSLY), provider of a global edge cloud platform, today released its “Behind the Screens” retrospective detailing 2019’s notable milestones in internet infrastructure, from the increased adoption of modernized protocols, to the growth in reach and capacity of global high-speed internet, and more. Fastly’s CTO and co-founder, Tyler McMullen, anticipates that these advancement...

Fastly, Inc. (NYSE: FSLY), provider of a global edge cloud platform, today released its “Behind the Screens” retrospective detailing 2019’s notable milestones in internet infrastructure, from the increased adoption of modernized protocols, to the growth in reach and capacity of global high-speed internet, and more. Fastly’s CTO and co-founder, Tyler McMullen, anticipates that these advancement...


12/11/2019 - 16:37

Invicro Supports the Alzheimer’s Disease Neuroimaging Initiative

Invicro LLC, a Konica Minolta Company, today announced funding support for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and two of their distinguished scientists within the Alzheimer’s biomarkers space, Drs. Roger Gunn and Kenneth Marek, will join the ADNI-Private Partner Scientific Board (PPSB). Invicro is a global provider of imaging biomarkers, core lab services, advanced analyti...

Invicro LLC, a Konica Minolta Company, today announced funding support for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and two of their distinguished scientists within the Alzheimer’s biomarkers space, Drs. Roger Gunn and Kenneth Marek, will join the ADNI-Private Partner Scientific Board (PPSB). Invicro is a global provider of imaging biomarkers, core lab services, advanced analyti...


12/11/2019 - 15:00

Sevan Elevate Brings Safety and Sustainability to New Heights

Sevan Multi-Site Solutions, Inc. (Sevan), a global leader in data analytics, surveys, design, program management and construction services, is excited to announce the launch of Sevan Elevate, a program that will reinforce and continuously improve Safety and Sustainability across the company to deliver excellence to people and clients. Safety and Sustainability have been a strategic imperativ...

Sevan Multi-Site Solutions, Inc. (Sevan), a global leader in data analytics, surveys, design, program management and construction services, is excited to announce the launch of Sevan Elevate, a program that will reinforce and continuously improve Safety and Sustainability across the company to deliver excellence to people and clients. Safety and Sustainability have been a strategic imperativ...


12/11/2019 - 14:30

Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), and Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”) announced today that the companies have entered into a clinical collaboration to conduct a Phase 2, multicenter study of mavrilimumab, an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor receptor alpha (GM-CSFRα), in combination with Y...

Kite, a Gilead Company (Nasdaq: GILD), and Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”) announced today that the companies have entered into a clinical collaboration to conduct a Phase 2, multicenter study of mavrilimumab, an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor receptor alpha (GM-CSFRα), in combination with Y...


12/11/2019 - 14:00

Lightbits Labs Launches Industry’s First NVMe/TCP Clustered Storage Solution

Lightbits Labs, the leader in NVMe™ over TCP (NVMe/TCP) software-defined disaggregated storage, today has advanced its software solution, LightOS, to deliver the first NVMe/TCP clustered storage solution. With more companies moving away from direct attached storage (DAS), and with storage requirements typically growing far faster than compute requirements, both public-cloud providers and pri...

Lightbits Labs, the leader in NVMe™ over TCP (NVMe/TCP) software-defined disaggregated storage, today has advanced its software solution, LightOS, to deliver the first NVMe/TCP clustered storage solution. With more companies moving away from direct attached storage (DAS), and with storage requirements typically growing far faster than compute requirements, both public-cloud providers and pri...


12/11/2019 - 14:00

DS-8201 ([Fam-] Trastuzumab Deruxtecan) Achieved A Tumor Response Rate of 60.9% in Pivotal Phase 2 HER2 Positive Metastatic Breast Cancer Trial

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today presented positive detailed data from the global pivotal phase 2 single-arm DESTINY-Breast01 trial of DS-8201 ([fam-] trastuzumab deruxtecan), an investigational HER2 targeting antibody drug conjugate (ADC), in patients with HER2 positive metastatic breast cancer. The data were part of the press program at the 20...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today presented positive detailed data from the global pivotal phase 2 single-arm DESTINY-Breast01 trial of DS-8201 ([fam-] trastuzumab deruxtecan), an investigational HER2 targeting antibody drug conjugate (ADC), in patients with HER2 positive metastatic breast cancer. The data were part of the press program at the 20...


12/11/2019 - 13:40

PSE: Sanofi joins Systems-based Pharmaceutics Alliance

The Systems-based Pharmaceutics Alliance welcomes Sanofi S.A. as its newest member. The Alliance further comprises leading pharma companies Eli Lilly and Company, GlaxoSmithKline Research & Development Limited, Pfizer Inc. and F. Hoffmann-La Roche Ltd., and supplier of mechanistic modelling software, Process Systems Enterprise Ltd. The Alliance is aimed at developing an integrated and ...

The Systems-based Pharmaceutics Alliance welcomes Sanofi S.A. as its newest member. The Alliance further comprises leading pharma companies Eli Lilly and Company, GlaxoSmithKline Research & Development Limited, Pfizer Inc. and F. Hoffmann-La Roche Ltd., and supplier of mechanistic modelling software, Process Systems Enterprise Ltd. The Alliance is aimed at developing an integrated and ...

12/13/2019 - 00:10

Amazon Studios Orders Fourth Season of the Award-Winning Comedy The Marvelous Mrs. Maisel

(NASDAQ:AMZN) – Amazon Studios announced today that it has ordered a fourth season of the Emmy and Golden Globe-Award winning comedy The Marvelous Mrs. Maisel. The third season premiered Friday, Dec. 6 on Amazon Prime Video in more than 200 countries and territories worldwide. The Marvelous Mrs. Maisel received two Golden Globe nominations this week, for Best Television Series, Musical or Come...

(NASDAQ:AMZN) – Amazon Studios announced today that it has ordered a fourth season of the Emmy and Golden Globe-Award winning comedy The Marvelous Mrs. Maisel. The third season premiered Friday, Dec. 6 on Amazon Prime Video in more than 200 countries and territories worldwide. The Marvelous Mrs. Maisel received two Golden Globe nominations this week, for Best Television Series, Musical or Come...


12/12/2019 - 20:25

“The ABCs of SMBs” – AGC’s Latest Insight Report on the $380B SMB Software & Services Market

AGC Partners is pleased to announce the release of its latest industry thought piece – “The ABCs of SMBs.” This piece explores the market for software and services selling into small and midsize businesses (SMB) globally, and the technology providers and strategies used to best penetrate this underserved and rapidly growing market. The low-cost ease of use SaaS delivery model has broken open t...

AGC Partners is pleased to announce the release of its latest industry thought piece – “The ABCs of SMBs.” This piece explores the market for software and services selling into small and midsize businesses (SMB) globally, and the technology providers and strategies used to best penetrate this underserved and rapidly growing market. The low-cost ease of use SaaS delivery model has broken open t...


12/12/2019 - 17:40

Mary Kay Advances Commitment to Global Female Empowerment at United Nations Global Compact Gender Equality Forum

In its ongoing commitment to female empowerment and entrepreneurship, Mary Kay Inc., alongside Warner Bros., Qualcomm and more, recently addressed the economic, social and sustainability benefits of global gender equality at the United Nations Global Compact for Gender Equality, an event organized by Global Compact Network USA (GCNUSA) in Los Angeles, California. The regional event took place ...

In its ongoing commitment to female empowerment and entrepreneurship, Mary Kay Inc., alongside Warner Bros., Qualcomm and more, recently addressed the economic, social and sustainability benefits of global gender equality at the United Nations Global Compact for Gender Equality, an event organized by Global Compact Network USA (GCNUSA) in Los Angeles, California. The regional event took place ...


12/12/2019 - 15:30

Andersen Global Strengthens Presence in Nigeria with The New Practice

Andersen Global entered into a Collaboration Agreement with Lagos-based law firm, The New Practice (TNP), increasing the global organization’s footprint in Africa and strengthening its presence in Nigeria. Founded in 2007, TNP’s practice includes Office Managing Partner Baba Alokolaro and more than 20 legal professionals. The firm provides a large range of commercially oriented legal service...

Andersen Global entered into a Collaboration Agreement with Lagos-based law firm, The New Practice (TNP), increasing the global organization’s footprint in Africa and strengthening its presence in Nigeria. Founded in 2007, TNP’s practice includes Office Managing Partner Baba Alokolaro and more than 20 legal professionals. The firm provides a large range of commercially oriented legal service...


12/12/2019 - 15:26

Luxembourg's Acceleration Programme Fit 4 Start Call for ICT and Space Tech Applications Open

Fit 4 Start is Luxembourg’s acceleration programme for supporting start-ups. Start-ups benefitting from the programme, established in Luxembourg or another country, including outside the European Union, are selected twice a year. Launched by the Ministry of the Economy and managed by Luxinnovation, the Fit 4 Start programme has opened its next call for candidates for national and international...

Fit 4 Start is Luxembourg’s acceleration programme for supporting start-ups. Start-ups benefitting from the programme, established in Luxembourg or another country, including outside the European Union, are selected twice a year. Launched by the Ministry of the Economy and managed by Luxinnovation, the Fit 4 Start programme has opened its next call for candidates for national and international...


12/12/2019 - 15:00

Seoul Semiconductor Extends Auction Date to February 28, 2020 Given Market Interest in Key Technology Patent Portfolio

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced it extends the auction date for radio frequency (RF) semiconductor patent portfolio and its high power LED package patent portfolio to February 28, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191212005201/en/S...

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced it extends the auction date for radio frequency (RF) semiconductor patent portfolio and its high power LED package patent portfolio to February 28, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191212005201/en/S...


12/12/2019 - 14:00

Priyanka Chopra Jonas and Crocs to Donate 50,000 Pairs of Classic Clogs to UNICEF

Crocs, Inc. (NASDAQ: CROX), in partnership with UNICEF Goodwill Ambassador Priyanka Chopra Jonas, today announced that 50,000 pairs of Crocs Classic clogs will be donated over the next year to underserved school children in Belize through UNICEF. This charitable contribution supports the actor’s joint mission to help children around the world and provide them with more opportunities to achieve...

Crocs, Inc. (NASDAQ: CROX), in partnership with UNICEF Goodwill Ambassador Priyanka Chopra Jonas, today announced that 50,000 pairs of Crocs Classic clogs will be donated over the next year to underserved school children in Belize through UNICEF. This charitable contribution supports the actor’s joint mission to help children around the world and provide them with more opportunities to achieve...


12/12/2019 - 12:02

EBRD invests in the rapidly growing Turkish tech company, obilet.com

European Bank for Reconstruction and Development (EBRD) invested in obilet.com, the online sales platform for users to purchase bus and airline tickets. EBRD, which offers financing for thousands of projects to support local growth in European countries, has invested $11 billion in Turkish businesses and projects to date. Earlybird Venture Capital, an investor in obilet.com, announced that it ...

European Bank for Reconstruction and Development (EBRD) invested in obilet.com, the online sales platform for users to purchase bus and airline tickets. EBRD, which offers financing for thousands of projects to support local growth in European countries, has invested $11 billion in Turkish businesses and projects to date. Earlybird Venture Capital, an investor in obilet.com, announced that it ...


12/12/2019 - 11:00

Thomas More Institute Analyses the Organisation and the Challenges of Islam in Morocco

With the rise of political Islam, terrorism, instability and tensions in Muslim countries, as well as integration difficulties in western countries, the question of Islam currently dominates the global agenda. Every country, whether it be in the Muslim world or outside of it, are searching for new equilibriums. It is within this context that the Thomas More Institute has looked into Morocco,...

With the rise of political Islam, terrorism, instability and tensions in Muslim countries, as well as integration difficulties in western countries, the question of Islam currently dominates the global agenda. Every country, whether it be in the Muslim world or outside of it, are searching for new equilibriums. It is within this context that the Thomas More Institute has looked into Morocco,...


12/12/2019 - 10:00

Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture

Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today signed an agreement to create a joint venture that will combine their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA will have a 70% controlling equity interest in the joint venture and McKesson will have a 30% ownership interest. This press ...

Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today signed an agreement to create a joint venture that will combine their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA will have a 70% controlling equity interest in the joint venture and McKesson will have a 30% ownership interest. This press ...

12/13/2019 - 19:55

Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under revie...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under revie...


12/13/2019 - 16:17

CreditLens™ Solution Receives SOC 2 Attestation Report

Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and ...

Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and ...


12/13/2019 - 12:47

CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of ...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of ...


12/13/2019 - 12:40

Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with ...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with ...


12/13/2019 - 10:24

German Player Karl Rupprec Wins 2019 Boyaa Poker Tournament Europe

On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213...

On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213...


12/13/2019 - 10:00

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by Italian Designed Architectural Lighting Brand for Motorized Luminaire with Smart Wireless Controls

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architec...

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architec...


12/13/2019 - 07:00

Heilind Asia Wins the 6th China “IoT Technology Innovation Award”

Heilind Asia Pacific, part of Heilind Electronics Inc., was invited to attend The 6th China IoT Summit held in Shenzhen on 12th Dec 2019 to meet with the world's leading companies in the field of IoT, jointly discussed and shared the market prospects of IoT industry, the latest IoT business model, cutting-edge technology programs and other industry topics. In the following Annual Awards Ceremo...

Heilind Asia Pacific, part of Heilind Electronics Inc., was invited to attend The 6th China IoT Summit held in Shenzhen on 12th Dec 2019 to meet with the world's leading companies in the field of IoT, jointly discussed and shared the market prospects of IoT industry, the latest IoT business model, cutting-edge technology programs and other industry topics. In the following Annual Awards Ceremo...


12/13/2019 - 05:00

Moody’s Analytics Wins Data Provider of the Year at Regulation Asia Awards for Excellence

Moody’s Analytics has won the Data Provider of the Year category at the 2019 Regulation Asia Awards for Excellence. We earned this recognition for the Moody’s Analytics Data Alliance and for Orbis, from Bureau van Dijk, a Moody’s Analytics company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191212005571/en/ Data Alliance is one...

Moody’s Analytics has won the Data Provider of the Year category at the 2019 Regulation Asia Awards for Excellence. We earned this recognition for the Moody’s Analytics Data Alliance and for Orbis, from Bureau van Dijk, a Moody’s Analytics company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191212005571/en/ Data Alliance is one...


12/13/2019 - 03:00

Protection Where You Need It: Heilind Leading Supplier TE Connectivity’s Heat Shrink Tubing

TE Connectivity (TE), a world leader in connectivity and sensors, provided Heat Shrink Tubing which is used for electrical insulation, mechanical protection, environmental sealing, and strain relief for applications such as back-end connector sealing, breakouts, and connector-to-cable transitions. It is a solid alternative to taping, molding or potting. When heated, it conforms to the size a...

TE Connectivity (TE), a world leader in connectivity and sensors, provided Heat Shrink Tubing which is used for electrical insulation, mechanical protection, environmental sealing, and strain relief for applications such as back-end connector sealing, breakouts, and connector-to-cable transitions. It is a solid alternative to taping, molding or potting. When heated, it conforms to the size a...


12/13/2019 - 02:43

OneConnect Announces Pricing of Initial Public Offering

OneConnect Financial Technology Co., Ltd. (OneConnect), a leading technology-as-a-service platform for financial institutions in China, today announced the pricing of its initial public offering of 31,200,000 American Depositary Shares (ADSs), each representing three ordinary shares, at a price to the public of US$10.00 per ADS. OneConnect has granted the underwriters an option to purchase up ...

OneConnect Financial Technology Co., Ltd. (OneConnect), a leading technology-as-a-service platform for financial institutions in China, today announced the pricing of its initial public offering of 31,200,000 American Depositary Shares (ADSs), each representing three ordinary shares, at a price to the public of US$10.00 per ADS. OneConnect has granted the underwriters an option to purchase up ...

12/07/2019 - 20:00

Kite Announces Long-term Data From ZUMA-1 Showing Approximately Half of Refractory Large B-cell Lymphoma Patients Were Alive Three Years After Yescarta Treatment

Kite, a Gilead Company (Nasdaq: GILD), today announced new data from the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with refractory large B-cell lymphoma. These results included updated overall survival data from the pivotal phase 2 study after three years following a single infusion of Yescarta, as well as an analysis from a separate safety management cohort of pati...

Kite, a Gilead Company (Nasdaq: GILD), today announced new data from the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with refractory large B-cell lymphoma. These results included updated overall survival data from the pivotal phase 2 study after three years following a single infusion of Yescarta, as well as an analysis from a separate safety management cohort of pati...


12/07/2019 - 16:20

Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR-T) therapy being evaluated in the treatment of patients with relapsed or refractory mult...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR-T) therapy being evaluated in the treatment of patients with relapsed or refractory mult...


12/07/2019 - 16:18

Imbruvica®▼(ibrutinib) Combination Therapy Data From Two Studies and Long-Term Integrated Analysis Presented at ASH 2019 Show Efficacy and Safety in First-Line Treatment of Chronic Lymphocytic Leukaemia

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL. Results from a 48-month follow-up analysis of the Phase 3 E1912 clinical study reported a statistically significant difference in PFS and OS f...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL. Results from a 48-month follow-up analysis of the Phase 3 E1912 clinical study reported a statistically significant difference in PFS and OS f...


12/07/2019 - 15:30

Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that results of the TOURMALINE-AL1 trial will be presented during an oral session at the 61st American Society of Hematology (ASH) annual meeting on Saturday, December 7, 2019 in Orlando, Florida. TOURMALINE-AL1 is a Phase 3, randomized clinical trial evaluating the effect of NINLAROTM (ixazomib) in combination with dexa...

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that results of the TOURMALINE-AL1 trial will be presented during an oral session at the 61st American Society of Hematology (ASH) annual meeting on Saturday, December 7, 2019 in Orlando, Florida. TOURMALINE-AL1 is a Phase 3, randomized clinical trial evaluating the effect of NINLAROTM (ixazomib) in combination with dexa...


11/30/2019 - 13:04

Saudi Fund for Development in Collaboration on Social Infrastructure Projects in Djibouti

The Saudi Fund for Development (SFD) recently signed an agreement for a grant package worth over USD $9 million to fund the design and construction of a water distribution network, a judicial courthouse and infrastructure projects in Dijbouti, marking the latest in a series of the SFD’s development projects in the country. This press release features multimedia. View the full release here: htt...

The Saudi Fund for Development (SFD) recently signed an agreement for a grant package worth over USD $9 million to fund the design and construction of a water distribution network, a judicial courthouse and infrastructure projects in Dijbouti, marking the latest in a series of the SFD’s development projects in the country. This press release features multimedia. View the full release here: htt...


11/23/2019 - 16:30

Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting

Takeda Pharmaceutical Company Limited (TSE:4502 / NYSE:TAK) (“Takeda”) today announced that updated results from the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial of its dengue vaccine candidate (TAK-003) were presented at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting. The data presented include an update on ove...

Takeda Pharmaceutical Company Limited (TSE:4502 / NYSE:TAK) (“Takeda”) today announced that updated results from the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial of its dengue vaccine candidate (TAK-003) were presented at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting. The data presented include an update on ove...


11/23/2019 - 04:00

Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG® (brigatinib) Continues to Demonstrate Superiority in the First-Line After Two Years of Follow-Up

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced updated data from the Phase 3 ALTA-1L trial, which evaluated ALUNBRIG versus crizotinib in adults with advanced anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. Results show after more than two years of follow-up, ALUNBRIG reduced the risk of diseas...

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced updated data from the Phase 3 ALTA-1L trial, which evaluated ALUNBRIG versus crizotinib in adults with advanced anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. Results show after more than two years of follow-up, ALUNBRIG reduced the risk of diseas...

12/01/2019 - 05:17

Seedland Launches Pilot Operation of China’s First Autonomous Commuter Vehicle: Hachi Auto

Seedland Group applied Hachi Auto, an autonomous vehicle for smart communities, in one of the Seedland communities “Boston Ivy” in early November 2019, becoming the first to bring UGV into residential communities in China. As a part of Seedland’s Smart Life System, Hachi Auto allows the community residents to experience the convenience brought by technological innovation. This press release fe...

Seedland Group applied Hachi Auto, an autonomous vehicle for smart communities, in one of the Seedland communities “Boston Ivy” in early November 2019, becoming the first to bring UGV into residential communities in China. As a part of Seedland’s Smart Life System, Hachi Auto allows the community residents to experience the convenience brought by technological innovation. This press release fe...


11/24/2019 - 14:38

Identity and Citizenship Authority’s New Services to UAE Residents

In line with the UAE Government’s endeavor to make the UAE a global hub for talents, investors and established businessmen, the Federal Authority for Identity And Citizenship Services (ICA) is expanding the range of its services and facilities for UAE residents who contribute in creating the community’s fabric. This press release features multimedia. View the full release here: https://www.bus...

In line with the UAE Government’s endeavor to make the UAE a global hub for talents, investors and established businessmen, the Federal Authority for Identity And Citizenship Services (ICA) is expanding the range of its services and facilities for UAE residents who contribute in creating the community’s fabric. This press release features multimedia. View the full release here: https://www.bus...


11/18/2019 - 00:42

Certain Units in Oosten Condominium Brooklyn, New York to be Tokenized Through UPRETS

Digitization of real estate assets is becoming a reality as UPRETS is now in the process of tokenizing certain condominium units at the Oosten property in Williamsburg, Brooklyn. The condominium that has 216 units will be the first property to have condominium units tokenized by UPRETS. New York has always been a big market for real estate, even after the 2008 housing crisis. This luxury proje...

Digitization of real estate assets is becoming a reality as UPRETS is now in the process of tokenizing certain condominium units at the Oosten property in Williamsburg, Brooklyn. The condominium that has 216 units will be the first property to have condominium units tokenized by UPRETS. New York has always been a big market for real estate, even after the 2008 housing crisis. This luxury proje...


11/18/2019 - 00:00

Vista Equity Partners Announces Asia Expansion

Vista Equity Partners today announced the opening of Vista Consulting Group’s (“VCG”, and together with Vista Equity Partners, “Vista”) Singapore office. VCG is the affiliated consulting arm of Vista, the leading investment firm focused on enterprise software, data, and technology-enabled businesses. The new office will serve as the Asia headquarters for VCG, expanding Vista’s presence and pro...

Vista Equity Partners today announced the opening of Vista Consulting Group’s (“VCG”, and together with Vista Equity Partners, “Vista”) Singapore office. VCG is the affiliated consulting arm of Vista, the leading investment firm focused on enterprise software, data, and technology-enabled businesses. The new office will serve as the Asia headquarters for VCG, expanding Vista’s presence and pro...


11/17/2019 - 18:39

Dubai Future Accelerators to Pick New Cohort of Innovative Startups to Address Global Challenges

Dubai Future Accelerators (DFA), an initiative of Dubai Future Foundation (DFF) and the Government of Dubai, is once again scouting new talent from among the world’s most innovative startups and scale-ups to join its flagship program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005057/en/Dubai Future Accelerators convened p...

Dubai Future Accelerators (DFA), an initiative of Dubai Future Foundation (DFF) and the Government of Dubai, is once again scouting new talent from among the world’s most innovative startups and scale-ups to join its flagship program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005057/en/Dubai Future Accelerators convened p...


11/17/2019 - 17:02

Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

A new interim analysis of three-year data from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) real-world study on effectiveness shows that empagliflozin was associated with a decreased risk of hospitalisation for heart failure and a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors and GLP-1 receptor agonists.1 The interim analysis...

A new interim analysis of three-year data from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) real-world study on effectiveness shows that empagliflozin was associated with a decreased risk of hospitalisation for heart failure and a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors and GLP-1 receptor agonists.1 The interim analysis...


11/17/2019 - 12:55

$1 Million Awarded to African Entrepreneurs in Grand Finale of the Jack Ma Foundation Africa Netpreneur Prize Initiative

Last night the Jack Ma Foundation hosted its first annual Africa Netpreneur Prize Initiative (ANPI) grand finale awarding $1 million in prize money to 10 entrepreneurs from across Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005049/en/Africa Netpreneur Prize Initiative Finale Judges (from left to right) - Strive Masi...

Last night the Jack Ma Foundation hosted its first annual Africa Netpreneur Prize Initiative (ANPI) grand finale awarding $1 million in prize money to 10 entrepreneurs from across Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005049/en/Africa Netpreneur Prize Initiative Finale Judges (from left to right) - Strive Masi...

Partners